187 related articles for article (PubMed ID: 9101355)
21. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF
Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581
[TBL] [Abstract][Full Text] [Related]
22. General toxicology of MnDPDP.
Larsen LE; Grant D
Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
[TBL] [Abstract][Full Text] [Related]
23. Manganese-calcium interactions with contrast media for cardiac magnetic resonance imaging: a study of manganese chloride supplemented with calcium gluconate in isolated Guinea pig hearts.
Bruvold M; Nordhøy W; Anthonsen HW; Brurok H; Jynge P
Invest Radiol; 2005 Mar; 40(3):117-25. PubMed ID: 15714086
[TBL] [Abstract][Full Text] [Related]
24. Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP.
Yang J; Wu EX
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4775-8. PubMed ID: 19964849
[TBL] [Abstract][Full Text] [Related]
25. Manganese toxicity upon overexposure.
Crossgrove J; Zheng W
NMR Biomed; 2004 Dec; 17(8):544-53. PubMed ID: 15617053
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
Gallez B; Bacic G; Swartz HM
Magn Reson Med; 1996 Jan; 35(1):14-9. PubMed ID: 8771018
[TBL] [Abstract][Full Text] [Related]
27. Thallium-like test for myocardial viability with MnDPDP-enhanced MRI.
Wendland MF; Saeed M; Bremerich J; Arheden H; Higgins CB
Acad Radiol; 2002 May; 9 Suppl 1():S82-3. PubMed ID: 12019904
[No Abstract] [Full Text] [Related]
28. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
Pomeroy OH; Wendland M; Wagner S; Derugin N; Holt WW; Rocklage SM; Quay S; Higgins CB
Invest Radiol; 1989 Jul; 24(7):531-6. PubMed ID: 2502502
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.
Gallez B; Baudelet C; Adline J; Geurts M; Delzenne N
Chem Res Toxicol; 1997 Apr; 10(4):360-3. PubMed ID: 9114970
[TBL] [Abstract][Full Text] [Related]
30. Spectroscopic monitoring of the cellular internalization of paramagnetic ions and their complexes: a perifused cells and perfused organs approach.
Muller RN; Vander Elst L; Colet JM; Herrent P; Séghi F; Pamart L; van Haverbeke Y
Acad Radiol; 1996 Aug; 3 Suppl 2():S277-81. PubMed ID: 8796580
[No Abstract] [Full Text] [Related]
31. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
[TBL] [Abstract][Full Text] [Related]
32. Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.
Grant D; Toft KG; Martinsen I; Atzpodien E
Acta Radiol; 1997 Jul; 38(4 Pt 2):732-9. PubMed ID: 9245969
[TBL] [Abstract][Full Text] [Related]
33. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.
Schmidt PP; Toft KG; Skotland T; Andersson K
J Biol Inorg Chem; 2002 Mar; 7(3):241-8. PubMed ID: 11935348
[TBL] [Abstract][Full Text] [Related]
34. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Young SW; Simpson BB; Ratner AV; Matkin C; Carter EA
Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
[TBL] [Abstract][Full Text] [Related]
35. Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.
Treinen KA; Gray TJ; Blazak WF
Teratology; 1995 Aug; 52(2):109-15. PubMed ID: 8588182
[TBL] [Abstract][Full Text] [Related]
36. Metabolism and pharmacokinetics of MnDPDP in man.
Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T
Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963
[TBL] [Abstract][Full Text] [Related]
37. Intracellular manganese ions provide strong T1 relaxation in rat myocardium.
Nordhøy W; Anthonsen HW; Bruvold M; Brurok H; Skarra S; Krane J; Jynge P
Magn Reson Med; 2004 Sep; 52(3):506-14. PubMed ID: 15334568
[TBL] [Abstract][Full Text] [Related]
38. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Skjold A; Amundsen BH; Wiseth R; Støylen A; Haraldseth O; Larsson HB; Jynge P
J Magn Reson Imaging; 2007 Sep; 26(3):720-7. PubMed ID: 17729351
[TBL] [Abstract][Full Text] [Related]
39. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
40. Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
Karlsson JO; Ignarro LJ; Lundström I; Jynge P; Almén T
Drug Discov Today; 2015 Apr; 20(4):411-21. PubMed ID: 25463039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
